AZ1508 | CAS#1817736-04-1 | tubulin inhibitor

MedKoo Cat#: 462286 | Name: AZ1508

Description:

WARNING: This product is for research use only, not for human or veterinary use.

AZ1508 is a drug-linker conjugates for ADC for the treatment of breast and stomach cancer, and the drug is a tubulin inhibitor.

Chemical Structure

AZ1508

CAS#1817736-04-1

Theoretical Analysis

MedKoo Cat#: 462286

Name: AZ1508

CAS#: 1817736-04-1

Chemical Formula: C56H85N9O11S

Exact Mass: 1091.6089

Molecular Weight: 1092.41

Elemental Analysis: C, 61.57; H, 7.84; N, 11.54; O, 16.11; S, 2.93

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

AZ1508; AZ 1508; AZ-1508

IUPAC/Chemical Name

(2S,4R)-4-(2-((1R,3R)-1-acetoxy-3-((2S,3S)-2-((2R,4R)-1,4-dimethylpiperidine-2-carboxamido)-N-ethyl-3-methylpentanamido)-4-methylpentyl)thiazole-4-carboxamido)-5-(4-((S)-6-amino-2-(6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamido)hexanamido)phenyl)-2-methylpentanoic acid

InChi Key

DONIIAXVJUFSOY-FJTITLMZSA-N

InChi Code

InChI=1S/C56H85N9O11S/c1-10-36(6)50(62-53(72)45-29-35(5)25-28-63(45)9)55(73)64(11-2)44(34(3)4)32-46(76-38(8)66)54-61-43(33-77-54)52(71)59-41(30-37(7)56(74)75)31-39-19-21-40(22-20-39)58-51(70)42(17-14-15-26-57)60-47(67)18-13-12-16-27-65-48(68)23-24-49(65)69/h19-24,33-37,41-42,44-46,50H,10-18,25-32,57H2,1-9H3,(H,58,70)(H,59,71)(H,60,67)(H,62,72)(H,74,75)/t35-,36+,37+,41-,42+,44-,45-,46-,50+/m1/s1

SMILES Code

O=C(N[C@]([H])(C(N([C@H](C[C@@H](OC(C)=O)C1=NC(C(N[C@@H](CC2=CC=C(C=C2)NC([C@@H](NC(CCCCCN3C(C=CC3=O)=O)=O)CCCCN)=O)C[C@@H](C(O)=O)C)=O)=CS1)C(C)C)CC)=O)[C@H](CC)C)[C@@H]4N(C)CC[C@H](C4)C

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 1,092.41 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Samantha Congreve, et al. Antibody drug conjugates (ADC) Current status and mapping of ADC:s in clinical programs. Uppsala Universitet.

View History

Description:

Chemical Structure

Theoretical Analysis

Price and Availability

Preparing Stock Solutions

View History

DCFBC

GSK2018682 HCl

Isooctyl monophosphate

HOE-316

TUG-2208

Pudafensine

Error message: